Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the County Health Plan topic
No spam. Unsubscribe anytime.
Court hears steep rise in health‑plan costs; directs staff to pursue direct‑provider contracts and a weight‑management option, and approves VeracityRx award
Summary
Consultants told commissioners that medical and pharmacy claims have risen sharply—GLP‑1 and other specialty drugs are driving pharmacy costs—and the court voted to pursue direct provider contracts, a county weight‑management program and to award a mail‑order personal‑importation contract to VeracityRx, subject to negotiation.
Cameron County commissioners on May 10 heard a detailed review of the county’s self‑insured health plan and voted to direct staff to pursue several cost‑control strategies, including direct provider contracts and a weight‑management program tied to GLP‑1 oversight. Separately, the court approved a recommendation to move forward with VeracityRx as the county’s personal‑importation mail‑order provider, subject to contract negotiation and final plan approval.
Valley Risk Consulting consultant Javier Leon told the court the plan’s year‑to‑date data raise concern: he reported medical claims and pharmacy totals and flagged six high‑cost drugs that account for a large share of current pharmacy spending. “As of January 2026, your medical claims are at $66,589,468. Pharmacy’s at $2,700,000,” he said; he also reported the plan’s stop‑loss and total plan figures in the presentation. Leon told the court that six specialty drugs comprise roughly 48% of pharmacy spend, and that five high‑cost claimants account for large dollar exposure on the medical side.
Recommendations and commissioner direction: Leon recommended pursuing direct contracts with local providers (primary‑care, urgent care and MRI centers) to secure discounts for the county and employees; negotiating reduced co‑pays and reimbursement rates with local urgent‑care vendors; issuing an RFP or qualification process for weight‑management centers that provide physician oversight, dietitians and lifestyle support tied to GLP‑1 access; and evaluating a mail‑order/personal‑importation program to lower prices for specialty drugs. Commissioners emphasized the need for “skin in the game” (co‑participation) for employees and asked staff to return with concrete implementation options quickly.
Personal importation and VeracityRx: The court considered RFP 260201 for prescription mail‑order services and, after a committee evaluation and a confidential cost tabulation provided to commissioners, staff recommended VeracityRx as the county’s personal‑importation provider. Staff said the program could deliver a 45%–65% discount on select drugs and waive co‑pays for participating employees, and estimated annual savings if heavily used. The court approved the recommendation and instructed staff to negotiate contract terms and return for final plan approval.
What it does not do: The court’s approval was for pursuing the recommendations and approving an RFP recommendation; commissioners did not set final exclusions, precise employee cost‑sharing, or an implementation timeline in this meeting. Several commissioners requested that staff return with specific contract language, financial scenarios and program guardrails before any operational changes take effect.
What’s next: staff will draft implementation options and return with detailed recommendations, and procurement will negotiate the VeracityRx contract for final court approval.
